Last quarter (Q4 2022), BillerudKorsnas AB's total revenue was kr11.97B, an increase of 78.99% from the same quarter last year. In Q4, BillerudKorsnas AB's net income was kr940.00M. See BillerudKorsnas AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	kr 42.59B	kr 42.59B	kr 1.28B	kr 23.88B	kr 24.45B	kr 23.90B
Cost of Revenue	kr 19.51B	kr 19.51B	kr 1.06B	kr 12.55B	kr 13.01B	kr 11.86B
Gross Profit	kr 23.08B	kr 23.08B	kr 216.00M	kr 11.33B	kr 11.44B	kr 12.04B
Operating Expense	kr 17.48B	kr 17.48B	kr 222.00M	kr 10.67B	kr 10.34B	kr 10.42B
Operating Income	kr 5.59B	kr 5.59B	kr -6.00M	kr 664.00M	kr 1.10B	kr 1.63B
Net Non Operating Interest Income Expense	kr -153.00M	kr -153.00M	kr -2.00M	kr -122.00M	kr -161.00M	kr -80.00M
Other Income Expense	-	-	kr -25.00M	-	-	-
Pretax Income	kr 5.87B	kr 5.87B	kr -6.00M	kr 679.00M	kr 1.26B	kr 1.34B
Tax Provision	kr 1.28B	kr 1.28B	kr -3.00M	kr 3.00M	kr 254.00M	kr 304.00M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr 4.59B	kr 4.59B	kr -3.00M	kr 660.00M	kr 6.72B	kr 1.04B
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 36.99B	kr 36.99B	kr 1.28B	kr 23.22B	kr 23.34B	kr 22.27B
Net Income From Continuing And Discontinued Operation	kr 4.59B	kr 4.59B	kr -3.00M	kr 660.00M	kr 6.72B	kr 1.04B
Normalized Income	kr 4.59B	kr 4.50B	-	kr 655.09M	kr 1.01B	kr 1.20B
Interest Expense	-	kr 158.00M	-	kr 117.00M	kr 122.00M	kr 83.00M
EBIT	kr 6.03B	kr 6.03B	kr -4.00M	kr 796.00M	kr 1.39B	kr 1.42B
EBITDA	kr 8.51B	kr 8.51B	kr 150.00M	kr 2.73B	kr 3.13B	kr 2.94B

Currency in SEK

BillerudKorsnas AB Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing